AgRP/NPY and POMC neurons in the arcuate nucleus and their potential role in treatment of obesity

MS Vohra, K Benchoula, CJ Serpell, WE Hwa - European journal of …, 2022 - Elsevier
Obesity is a major health crisis affecting over a third of the global population. This
multifactorial disease is regulated via interoceptive neural circuits in the brain, whose …

Mortality in patients with pituitary disease

M Sherlock, J Ayuk, JW Tomlinson… - Endocrine …, 2010 - academic.oup.com
Pituitary disease is associated with increased mortality predominantly due to vascular
disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor …

Craniopharyngiomas

N Karavitaki, S Cudlip, CBT Adams… - Endocrine …, 2006 - academic.oup.com
Craniopharyngiomas are rare, mainly sellar/parasellar, epithelial tumors diagnosed during
childhood or adult life. Histologically, two primary subtypes have been recognized …

Moderate aerobic exercise training prevents the augmented hepatic glucocorticoid response induced by high-fat diet in mice

J Dassonvalle, F Díaz-Castro… - International journal of …, 2020 - mdpi.com
Glucocorticoids (GCs) are critical regulators of energy balance. Their deregulation is
associated with the development of obesity and metabolic syndrome. However, it is not …

Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome

U Saleem, M Khaleghi, NG Morgenthaler… - The Journal of …, 2009 - academic.oup.com
Context: Stress-mediated hypothalamic-pituitary-adrenal axis activation, regulated by
arginine vasopressin (AVP), may have a role in the pathophysiology of metabolic syndrome …

GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases

F Zoicas, M Droste, B Mayr… - European journal of …, 2013 - academic.oup.com
Background Patients with hypothalamic pathology often develop morbid obesity, causing
severe metabolic alterations resulting in increased morbidity and mortality. Glucagon-like …

Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment

RH Lustig - Frontiers in endocrinology, 2011 - frontiersin.org
Obesity is a common complication after craniopharyngioma therapy, occurring in up to 75%
of survivors. Its weight gain is unlike that of normal obesity, in that it occurs even with caloric …

Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity

CL Roth, H Eslamy, D Werny, C Elfers, ML Shaffer… - …, 2015 - Wiley Online Library
Objective Excessive weight gain frequently occurs in patients with hypothalamic tumors and
lesions leading to hypothalamic obesity (HO). Methods Digital brain magnetic resonance …

Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma

A Bogusz, S Boekhoff, M Warmuth-Metz… - Endocrine …, 2019 - ec.bioscientifica.com
Objective Quality of life (QoL) is frequently impaired in childhood-onset craniopharyngioma
(CP) by hypothalamic syndrome. The debate, whether pretreatment hypothalamic …

[HTML][HTML] Genetics of non-syndromic childhood obesity and the use of high-throughput DNA sequencing technologies

ACP da Fonseca, C Mastronardi, A Johar… - Journal of Diabetes and …, 2017 - Elsevier
Background Childhood obesity is a serious public health problem associated with the
development of several chronic diseases, such as type 2 diabetes mellitus, dyslipidemia …